Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mexiletine-associated left ventricular dysfunction: a case study.

S L Ballas1, K L Baughman, L S Griffith

  • 1Sinai Hospital of Baltimore, MD 21215.

Maryland Medical Journal (Baltimore, Md. : 1985)
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.

Journal of lipid research·2009
Same author

Takayansu's Arteritis Associated with Anterior Uveitis and Cutaneous Extravascular Necrotizing Granuloma.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia.

International journal of clinical practice·2004
Same author

Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies.

International journal of clinical practice·2003
Same author

Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia.

European heart journal·2003
Same author

Peripartum cardiomyopathy.

Minerva cardioangiologica·2003
Same journal

Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Seroprevalence study of Hantavirus infection in the community based population.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Pneumomediastinum: the Valsalva crunch.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Hepatic hydrothorax: diagnosis and management. Case report and review of the literature.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

A case of post-streptococcal reactive arthritis.

Maryland medical journal (Baltimore, Md. : 1985)·2000
Same journal

Sexual practices of older adults in a high HIV prevalence environment.

Maryland medical journal (Baltimore, Md. : 1985)·2000
See all related articles

Mexiletine, a lidocaine analogue for ventricular arrhythmias, may harm patients with weakened heart function. It can cause significant negative inotropic effects, reducing the heart

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Mexiletine is a Class IB antiarrhythmic drug.
  • It is structurally similar to lidocaine.
  • Used for treating ventricular arrhythmias.

Observation:

  • Mexiletine's effects were evaluated in patients with compromised left ventricular function.
  • Negative inotropic effects were assessed.

Findings:

  • Mexiletine demonstrated clinically significant negative inotropic effects.
  • These effects were observed in patients with baseline diminished left ventricular function.

Implications:

  • Caution is advised when prescribing mexiletine to patients with impaired cardiac function.
  • Risk-benefit assessment is crucial for this patient population.

Related Experiment Videos

  • Further research may be needed to explore alternative antiarrhythmic strategies.